This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Dsm N.v.. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2002
Title: Yvonne Johanna Vos: Innovator in Biotechnology
Introduction
Yvonne Johanna Vos is a prominent inventor based in Capelle a/d Ijssel, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the area of human interleukin-3 research. With a total of 2 patents to her name, Vos has established herself as a key figure in her domain.
Latest Patents
Her latest patents include groundbreaking work on the expression and purification of human interleukin-3 and its muteins. The inventions relate to nucleotide sequences encoding human interleukin-3 (hIL-3), as well as recombinant DNAs, expression cassettes, transformed host cells, and recombinant expression methods that utilize these sequences. Additionally, her patents describe proteins with hIL-3 activity, whether purified, recombinantly produced, or in fusion protein forms. These innovations also encompass methods for using such proteins to produce antibodies that can specifically react with hIL-3.
Career Highlights
Yvonne Vos has built a successful career at DSM N.V., where she continues to advance her research and development efforts. Her work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications in medicine.
Collaborations
Throughout her career, Vos has collaborated with notable colleagues, including Gerard Wagemaker and Lambertus Christiaan Johannes Dorssers. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion
Yvonne Johanna Vos is a distinguished inventor whose work in biotechnology has led to significant advancements in the understanding and application of human interleukin-3. Her contributions continue to influence the field and hold promise for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
